Skip to main content
PLOS One logoLink to PLOS One
. 2024 Oct 24;19(10):e0312355. doi: 10.1371/journal.pone.0312355

‘Patera syndrome’ during the COVID-19 pandemic in the Canary Islands (Spain)

Elena Pisos-Álamo 1,#, Michele Hernández-Cabrera 1, Laura López-Delgado 1, Nieves Jaén-Sánchez 1, Christian Betancort-Plata 1, Carmen Lavilla Salgado 1, Laura Suárez-Hormiga 1, Marta Briega-Molina 2, Cristina Carranza-Rodríguez 3,*, Margarita Bolaños-Rivero 4, Araceli Hernández-Betancor 4, José-Luis Pérez-Arellano 3,#
Editor: Felix Bongomin5
PMCID: PMC11500946  PMID: 39446793

Abstract

Background

The number of migrants arriving on the shores of the Canary Islands continues to increase. The conditions under which the crossing is made, in small crowded, unsanitary boats (pateras or cayucos), have many and significant health problems.

Objective

To describe the demographic, clinical, microbiological characteristics and evolution of a series of patients who recently arrived by patera and required hospitalization.

Patients and methods

This observational, cross-sectional, and retrospective study included all patients newly arrived in Gran Canaria (Spain) by patera or cayuco from 2020 to 2022. Acute patera syndrome (APS) was defined as one or more of the following: dehydration, hypothermia, shock or rhabdomyolysis. Skin and soft tissue or musculoskeletal patera syndrome (SSTMSPS) was defined as conditions characterized by lesions of the skin, subcutaneous tissue, bone, or joint, excluding superficial erosions.

Results

During the study period, 193 migrants were admitted, mostly males with a median age of 23 years from West Africa. A total of 36.99% presented with APS with a single diagnostic criterion (most commonly dehydration, 86.9%), 11.56% with SSTMPS and 51.44% with both syndromes. A total of 109 patients presented with SSTMSPS, the most common being lower extremity ulcers. The most frequently isolated microorganisms were gram-negative (i.e. Shewanella algae). The McMahon score effectively predicted the need for renal replacement therapy in cases of rhabdomyolysis. Twenty patients presented with pneumomediastinum, which was benign. SARS-CoV-2 infection was not a problem in any of them. Surgical intervention was required in 22% of cases, including 8 amputations, all of which were minor. No patient died during admission.

Conclusion

Patera syndrome has specific characteristics that should be identified promptly to initiate the most effective treatment for optimal outcomes.

Introduction

For geographical reasons, Spain is a frequent destination for irregular migrants from Africa. The two main routes of entry are the Atlantic (to the Canary Islands) and the Mediterranean (by sea to Andalusia, and by land to the tiny Spanish enclaves of Ceuta and Melilla on the North African coast) (Fig 1). Regarding the Canary Islands, the province of Las Palmas has received the largest number of migrants.

Fig 1. Irregular migration routes to Europe.

Fig 1

Based on https://d-maps.com/carte.php?num_car=3138&lang=es.

Irregular migration by sea to the Canary Islands since the end of the 20th century has followed a biphasic pattern, with a first wave between 1997 and 2010, a sharp decrease between 2010 and 2017, and a progressive increase until now (Fig 2) [1]. In fact, the highest historical figure (39,910) was reached in the Canary Islands in 2023 [1]. This recent increase is partly related to border restrictions in the Maghreb due to the SARS-Cov-2 pandemic.

Fig 2. Number of irregular migrants arriving in the Canary Islands by sea.

Fig 2

This journey is usually made in small boats called pateras (with a capacity of 10 to 20 people) or cayucos (with a capacity of 40 to 70 individuals) [2, 3]. The long duration of the voyage (which can last up to two weeks) and the large number of passengers, often exceeding the maximum capacity, create a series of unsuitable conditions that are responsible for the occurrence of health problems [25]. For example, the mobility of the passengers is restricted, both by the lack of space and sometimes by the use of ropes to prevent them from falling into the sea or the boat from capsizing. Passengers are also exposed to low temperatures, scarce supplies of fresh water and food, and inadequate hygiene conditions. As a result, migrants often suffer from malnutrition, ingest salt water or water contaminated with urine or feces, and/or develop skin and soft tissue and/or musculoskeletal injuries that are related to contact with biological fluids, rotting food, or fuel-water emulsions.

A significant number of migrants, although not precisely quantified, perhaps as many as one third, may die during the voyage [2, 3]. There is little information on the health problems of migrants who have recently arrived in Europe and the results vary according to the migration route (Canary Islands, Western or Central Mediterranean) and the date of the study [2, 68]. Fortunately, most of the irregular migrants arriving by sea do not require health care or present with minor health problems that can be treated on an outpatient basis. However, a small but numerically significant percentage require hospital admission [2, 6].

In our geographical area, two types of serious manifestations have been previously described in these patients: acute alterations such as hypothermia, dehydration, shock or rhabdomyolysis [9], and cutaneous-musculoskeletal lesions such as ulcers, tenosynovitis, fasciitis or osteomyelitis [4, 5].

Therefore, the aim of this study was to describe the demographic, clinical, microbiological characteristics and evolution of a large series of newly arrived ‘patera’ patients requiring hospital admission.

Patients and methods

Study design, setting and subjects

This observational, cross-sectional, retrospective study was conducted at the Hospital Universitario Insular de Gran Canaria (Spain), which treats patients over 14 years of age. The study population included all hospitalized patients who had recently arrived in Gran Canaria (Spain) by small boat (patera or cayuco) between 1 January 2020 and 31 August 2022.

Variables

The following data were collected for each patient: i) epidemiologic data, including age, sex, country and region of origin, year and month of arrival; ii) general clinical data at the time of admission, including temperature, blood pressure, heart rate and respiratory rate, and clinical signs of dehydration; iii) skin and soft tissue and/or musculoskeletal lesions at the time of admission; iv) other clinical manifestations not included above; v) laboratory tests (complete blood count (CBC), serum biochemical parameters and urinalysis) obtained during the patient’s first visit to the emergency department and 72 h later; vi) chest X-ray, including specifically the presence of pneumomediastinum, subcutaneous emphysema, pneumothorax and pneumoperitoneum; vii) PCR detection of SARS-CoV2 using the Allplex 2019-nCoV assay (Seegene®, Seoul, South Korea), coproparasitic examination (Ritchie’s Method and Kato-Katz tests), serological tests for HIV, HBV, HCV, and the treponemal test for syphilis using the chemiluminescent microparticle immunoassay (CMIA) (Abbot®). If the treponemal test was positive, the study was extended using the rapid plasma reagin (RPR) agglutination technique (Chronolab Systems®). The diagnosis of malaria was based on blood smear examination, immunochromatography (BinaxNOW Malaria, Abbott®) and multiplex real-time PCR (Altona Diagnostics®); viii) culture of skin and/or musculoskeletal lesions whenever possible; ix) blood, stool, and urine cultures in certain circumstances, and x) patient evolution, including the need for and type of surgical intervention for skin and/or musculoskeletal lesions, admission to intensive care (ICU), length of hospital stay and in-hospital mortality.

Study definitions

The following definitions were used:

  • Acute patera syndrome (APS): one or more of the following symptoms was noted: dehydration, hypothermia, shock or rhabdomyolysis. The presence of dehydration was based on classic physical signs and/or determination of a BUN/creatinine ratio greater than 25 [10, 11]. Patients with dehydration were classified into three groups: isotonic, hypertonic, or hypotonic, based on plasma osmolality (measured or calculated) [10, 11]. Hypothermia was considered when the body temperature was below 35° [12]. Shock was defined as the presence of at least three of the following: tachycardia (> 100 bpm), tachypnea (≥ 22/min), hypotension (mean arterial pressure less than 65 mm Hg) or metabolic acidosis (low HCO3 and low pH in plasma). Rhabdomyolysis was defined according to published criteria when CK (creatine kinase) activity exceeded the cut-off value of > 1,000 IU/L or CK > 5 × ULN [13, 14]. The severity of rhabdomyolysis was classified according to Farkas’ criteria [15, 16] and the risk of acute renal failure according to the McMahon score [17].

  • Skin and soft tissue or musculoskeletal patera syndrome (SSTMSPS): All patients with skin, subcutaneous tissue, bone or joint lesions were included and patients with superficial erosions were excluded. Lesions (single or multiple) located in one or more anatomical regions were distinguished according to topography. The regions evaluated were the feet, other areas of the lower extremities, buttocks, sacrum, upper extremities and other areas (e.g. head, thorax, back or genitalia). The lesions were classified into five groups according to depth: cellulitis, ulcer (necrotic or purulent), abscess, fasciitis and osteoarticular involvement (tenosynovitis or osteomyelitis). Whenever possible, samples were obtained for microbiological study. In cases with positive culture, monomicrobial and polymicrobial forms were distinguished and the species involved were identified.

  • COVID-19: WHO criteria were used to classify the severity of infection as mild (uncomplicated illness, including non-specific symptoms); pneumonia (no signs of severe pneumonia and no need for supplemental oxygen); severe pneumonia (fever or suspected respiratory infection plus one of the following: respiratory rate > 30 breaths/min; severe respiratory distress or SpO2 93% on room air) [18].

Statistical analysis

Data analysis was performed using the DATAtab Online Statistical Calculator for Mac®. There were some missing data in the patient notes, which was noted in the analyses. Normality of data was assessed by the Kolmogorov-Smirnov test and homogeneity of variance by Levene’s test.

Categorical data were presented as frequencies and percentages and continuous data as means and standard deviations (SD) or median and interquartile range (IQR), as appropriate.

Categorical variables were compared using Pearson’s chi-squared test or Fisher’s exact test, when indicated. Student’s t test or ANOVA were used to compare two or more normally distributed continuous independent variables, while the Mann-Whitney or Kruskal Wallis tests were used as nonparametric tests. When significant differences were detected by ANOVA or Kruskal-Wallis tests, post-hoc tests (Bonferroni or Dunn-Bonferroni) were used. The Pearson or Spearman correlations were used to evaluate correlations between variables, depending on the sample distribution.

Statistical significance was determined using a two-sided p-value of less than 0.05.

Ethical aspects

The study was conducted in accordance with the protocol and principles of the current revised version of the Declaration of Helsinki (Fortaleza, October 2013) and approved by the Ethics Committee, protocol number 2024-070-1.

The data and clinical images were collected as part of routine care by the responsible clinical team and were anonymized at the point of extraction. None of the clinical images allowed patient identification. Patient consent was not obtained due to the retrospective nature of the study.

Results

Demographic data

A total of 193 patients were included: 35 were women (5 of whom were pregnant). Table 1 shows the age of the migrants according to sex. The statistical study showed significant differences between males and females, with age being higher in females. Most of the patients came from West Africa, followed by North Africa (Table 1). In terms of country of origin, most patients came from Mali, followed by Morocco and Côte d’Ivoire).

Table 1. Epidemiologic data.

Male Female Total
Number (percentage) 158 (89) 35 (11) 193 (100%)
Age*, Mean (SD) 23.69 (5.96) 28.26 (5.04) 24.52 (6.05)
Geographical area ** Country **
North Africa 41 0 41
Morocco 41 0 41
West Africa 101 29 130
Burkina Faso 2 0 2
Cameroon 1 0 1
Central Africa 1 0 1
Côte d’Ivoire 6 25 31
Gambia 9 1 10
Ghana 1 0 1
Guinea 5 3 8
Guinea Bissau 1 0 1
Liberia 1 0 1
Mali 54 0 54
Mauritania 2 0 2
Nigeria 1 0 1
Senegal 19 0 19

* p < 0.001

** Data were not available for 21 patients

Fifty-eight patients arrived in 2020, 125 in 2021 and 10 in 2022. The distribution of admissions according to month is shown in Fig 3, with the majority being between August and December.

Fig 3. Distribution of arrivals by month.

Fig 3

Clinical syndromes

Some 36.99% of patients presented with APS with a single diagnostic criterion, 11.56% with SSTMSPS without APS and 51.44% with both syndromes (Table 2); 20 patients had criteria for none of these syndromes. In the latter cases, the final diagnosis was bronchopneumonia (1), lobar pneumonia (2), obstetric complications (3), Plasmodium falciparum infection (1), pneumo-mediastinum (2), pneumothorax and tuberculosis (1). A final diagnosis could not be made in 9 patients.

Table 2. Clinical differences between the main types of ‘Patera syndrome’.

APS* SSTMSPS* APS + SSTMSPS* P value
Number (percentage) 64/173 (36.99) 20/173 (11.56) 89/173 (51.44)
Male/Female ratio** 55 /9 (6:1) 15/5 (3:1) 71/18 (4:1) 0.45
Age (years), Mean (SD)*** 25 (7) 26 (8) 24 (5) 0.31
Geographic area ** 0.11
    North Africa 19/56 5/19 14/77
    Western Africa 37/56 14/19 63/77
Criteria for APS **
    Dehydration 54/64 - 79/89 0.46
    Hypothermia 6/64 - 19/89 0.04
    Shock 3/64 - 6/89 0.63
    Rhabdomyolysis 43/64 - 67/89 0.27
SSTMSPS ** 0.78
    One anatomical region - 11/20 52/89
    >1 anatomical region - 9/20 37/89
Average hospital stay (days)*** Median (IQ range) 7 (4–12) 9 (6–15) 11(6–25) 0.02
Intensive Care Unit (ICU) admission ** 1/64 7/20 4/89 < 0.01

* APS: Acute Patera Syndrome; SSTMSPS: Skin and Soft Tissue or Musculoskeletal Patera Syndrome

**χ2

***ANOVA test

**** Kruskal-Wallis test.

Among the diagnostic criteria of APS, the most common was the presence of dehydration (86.9%), followed by rhabdomyolysis (71.9%), hypothermia (16.3%) and shock (5.8%). According to the plasma osmolality data, 27% had a hypertonic form (> 295 mOsm/kg), 31.5% an isotonic form (285–295 mOsm/kg) and another 31.5% a hypotonic form (< 285 mOsm/kg). The presence of rhabdomyolysis was documented in 110 patients: 69 were mild (62.7%), 33 moderate (30%) and 8 severe (7.3%). Although less common, hypothermia was significantly associated with cases of APS with concomitant skin, soft tissue, and musculoskeletal involvement.

Superficial skin involvement is practically universal in migrants arriving by boat. Less frequently, deeper layers of the skin, soft tissues or musculoskeletal structures are involved, which was observed in 109/193 (56%) of patients in this series (Fig 4).

Fig 4. Morphologic types of SSTMSPS.

Fig 4

A: Cellulitis; B: Purulent ulcers; C: Necrotic ulcer; D: Fasciitis; E: Tenosynovitis; F: Osteomyelitis.

Table 3 shows the anatomical regions involved and the type of lesions according to their depth. In 63 patients, a single region was involved, and in 46 patients, multiple (two or more) areas. In terms of depth, most lesions were ulcers (purulent, necrotic, or mixed), with cellulitis being another common manifestation.

Table 3. Clinical differences between the main types of patera syndrome.

Number Percentage
Anatomical region
Feet 30 18.40
Lower limbs (not feet) 46 28.22
Buttocks 33 20.25
Sacrum 6 3.68
Upper limbs 38 23.31
Other 10 6.13
Total 163 100
Depth of injury
Cellulitis 23 14.11
Ulcer/s 121 74.23
Abscess 5 3.07
Fasciitis 6 3.68
Musculoskeletal 8 4.91
Total 163 100

With the exception of cellulitis, the rest of the lesions were cultured. Of 109 cultures performed, 49 were negative, 18 were monomicrobial and 38 were polymicrobial. In the remainder, and excluding contaminants, 99 different microorganisms were identified, as shown in Table 4.

Table 4. SSTMSPS (Skin and soft tissue or musculoskeletal patera syndrome) microbiological data.

Facultative anaerobic and obligate aerobic bacteria
Gram stain Order Family Genus Species Number
Positive 42
Corynebacteriales Corynebacteriaceae Corynebacterium C. diphtheriae 1
Lactobacillales Enterococcaceae Enterococcus E. faecalis.
E. raffinosus
E. thailandicus
3
Bacillales Staphylococcaceae Staphylococcus S. aureus 25
Lactobacillales Streptococcaceae Streptococcus S. agalactiae 3
S. dysgalactiae 4
S. pyogenes 6
Negative 48
Aeromonadales Aeromonadaceae Aeromonas A. hydrophila 1
Enterobacterales Enterobacteriaceae Enterobacter E. cloacae 1
Escherichia E. coli 5
Klebsiella K. aerogenes 2
K. pneumoniae
Morganellaceae Morganella M. morganii 8
Proteus P. mirabilis 3
P. vulgaris
Providencia P. stuarti 2
Pseudomonadales Pseudomonadaceae Pseudomonas P. aeruginosa 7
P. hauseri 1
Alteromonadales Shewanellaceae Shewanella S. algae 13
Vibrionales Vibrionaceae Vibrio V. alginolyticus 5
Obligate anaerobic bacteria 
Gram stain
Positive 1
Clostridia Peptoniphilaceae Finegoldia F. magna 1
Negative 6
Bacteroidales Bacteroidaceae Bacteroides B. fragilis 5
Fusobacteriales Fusobacteriaceae Fusobacterium F. varium 1
Yeasts
Saccharomycetales Saccharomycetaceae Candida C. tropicalis 2

Analytical data

Several sources of analytical data were used in the initial definition of APS (time 0), as mentioned above. However, after performing the initial therapeutic maneuvers (mainly rehydration), noteworthy differences were observed (see Repository). Table 5 shows only the main data from the laboratory studies obtained 72 hours after admission to the emergency department, following stabilization of the patient.

Table 5. Analytical data at 72 hours.

All Patients Acute Patera Syndrome (APS) Skin and Soft Tissue or Musculoskeletal Patera Syndrome (SSTMSPS) APS plus SSTMSPS P value
Anemia 92/162(56.8%) 28/50 9/18 47/77 0.84
Mean corpuscular volume MCV (fl) 0.75
Decreased (< 80) 31/192(16,7%) 9/50 3/20 18/89
Normal (80–100) 158/192(82.3%) 39/50 17/20 71/89
Elevated (> 100) 3/192 (1.6%) 2/50 0/20 0
Total leukocytes /μL 0.90
Decreased (< 4,000) 111/158(70.2%) 32/50 11/19 52/77
Normal (4.000–11.000) 41/158 (25.9%) 14/50 7/19 20/77
Elevated (> 11.000) 6/158 (3.8%) 4/50 1/19 5/77
Eosinophils/μL 0.99
Elevated (> 450) 19/163 (11.6%) 5/50 2/18 9/77
Platelets (x 10 3 /μL) 0.20
Decreased (<150) 19/193(11.6%) 4/50 1/18 14/77
Normal (150–400) 158/193(82.4%) 38/50 17/18 58/77
Elevated (> 400) 16/193 (8,3%) 8/50 0/18 5/77
Plasma creatinine level (mg/dL) 0.4
Decreased (< 0.8) 119/163(73,0%) 35/52 11/16 61/77
Normal (0.8–1.2) 42/163 (25.7%) 16/52 5/16 15/77
Elevated (> 1.2) 2/163 (1.3%) 1/52 0/16 1/77
Na+ (mEq/L) 0.23
Decreased (< 135) 23/155 (14.8%) 12/47 1/16 10/75
Normal (135–145) 123/155(79.3%) 33/47 15/16 58/75
Elevated (> 145) 9/155 (5.8%) 2/47 0/16 7/75
K+ (mEq/L) 0.74
Decreased (< 3,5) 5/155 (3.2%) 1/47 0/16 3/75
Normal (3,5–5,0) 147/155(94.8%) 45/47 15/16 71/75
Elevated (> 5,0) 3/155 (2.0%) 1/47 1/16 1/75
AST (U/L) <0.01
Normal (0–35) 35/192 (18.2%) 5/63 11/20 8/89
Elevated (36–108) 157/192(81.8%) 29/63 6/20 37/89
Very high (>108 UNL) 75/193 (38.8%) 29/63 3/20 44/89
ALT (U/L) 0.13
Normal (0–44) 96/192 (50%) 30/64 15/20 38/89
Elevated (45–135) 96/192 (50%) 29/64 4/20 43/89
Very high (>135 UNL) 14/192 (7.3%) 5/64 1/20 8/89
LDH (U/L) 0.31
Normal (0–247) 35/192 (18.2%) 11/61 5/20 8(89
Elevated (248–744) 157/192(81.8%) 45/61 13/20 72/89
Very high (> 744 UNL) 16/192 (8.3%) 5/61 2/20 9/89

2 test

Radiology

In addition to other specific data (i.e. lobar pneumonia, bronchopneumonia, tuberculosis or hydatidosis), 20 patients (10.3% of the total) presented radiological data suggestive of extrapulmonary air not related to trauma or iatrogenesis (Fig 5). The most common manifestation was pneumomediastinum (20 patients) associated with subcutaneous emphysema in 8 cases, and pneumothorax or pneumoperitoneum in two different patients. There was no statistically significant association between the presence of extrapulmonary air and SARS-CoV2 infection.

Fig 5. Extrapulmonary air.

Fig 5

A: Pneumomediastinum; B: Subcutaneous emphysema; C: Pneumothorax; D. Pneumoperitoneum.

Microbiological studies

Thirty-seven of the 193 patients (19%) were infected with SARS-CoV2: 21 were asymptomatic and 16 had mild COVID-19. Of 178 patients evaluated, 4 were infected with HIV. Eight of 154 migrants had a positive syphilis (treponemal) test, all of which were RPR negative. Regarding primary hepatotropic virus serology, 32 of 141 had data of past HBV infection (HBcAb + HBAg -) and 20 of 141 had current infection (HBcAb + HBAg +). None of the patients were HCV-infected.

Other diseases

In addition to the above data, the presence of other diseases was evaluated and classified as acquired before the trip; acquired before or during the trip; and complications during admission. Among the pre-trip diseases, infectious causes [n = 7; Echinococcus granulosus (1), Mycobacterium tuberculosis (2), Plasmodium falciparum (3) and Strongyloides stercoralis (1)] and non-infectious causes [n = 5; Behçet’s disease (1), rheumatic heart disease, sickle cell disease (1) and type 1 diabetes mellitus (2)] were distinguished. The main diseases acquired before and/or during the trip were: Giardia duodenalis infection (11), Salmonella enterica subsp. enterica infection (7), scabies (5) and respiratory pathogens [n = 5]; Streptococcus pneumoniae (2), rhinovirus/enterovirus (2) and influenza B virus (1). Complications during hospitalization were nosocomial pneumonia (4), catheter-related bloodstream infection (4), pulmonary embolism (2), urinary tract infection (2), perforation of the gastrointestinal tract (1), subarachnoid hemorrhage (1) and postinfectious glomerulonephritis (1).

Evolution

The initial empiric treatment given is shown in Table 6. It was later modified in accordance with the microbiological data obtained. At least one surgical procedure was required in 24 of the 109 patients with SSTMSPS (22%) (Table 7). Debridement and cleaning were performed in all cases, reconstructive plastic surgery in 11 patients and partial limb amputation in 8 patients. All were minor, according to Ratliff’s classification [19] (6 trans phalangeal, 1 Chopart, 1 Pirogoff). ICU admission was required in 12 patients, with significant differences between clinical syndromes, being more frequent in patients with SSTMSPS (Table 2). The overall median stay was 9 days (IQR: 11) with a significant association between longer stay and the presence of both syndromes (APS and SSTMSPS) (Table 2). None of the patients died during hospital admission.

Table 6. Empiric antimicrobial treatment of SSTMSPS (Skin and soft tissue or musculoskeletal patera syndrome).

Empiric treatment n %
Amoxicillin/clavulanate-based 79 74.53
Amoxicillin/clavulanate plus Doxycycline 46 43.40
Amoxicillin/clavulanate 29 27.36
Amoxicillin/clavulanate plus Clindamycin 4 3.77
Carbapenem-based 11 10.38
Meropenem plus Doxycycline 4 3.77
Meropenem 3 2.83
Meropenem plus Doxycycline plus Linezolid 1 0.94
Imipenem 2 1.89
Ertapenem plus Ciprofloxacin 1 0.94
Piperacillin/Tazobactam-based 8 7.55
Piperacillin/Tazobactam 3 2.83
Piperacillin/Tazobactam plus Doxycycline 2 1.89
Piperacillin/Tazobactam plus Daptomycin 1 0.94
Piperacillin/Tazobactam plus Doxycycline plus Linezolid 1 0.94
Piperacillin/Tazobactam plus Linezolid 1 0.94
Piperacillin/Tazobactam plus Levofloxacin 1 0.94
Others 7 6.60
Ciprofloxacin plus Clindamycin 2 1.89
Levofloxacin 1 0.94
Levofloxacin plus Daptomycin 1 0.94
Ceftriaxone 2 1.89
Cefazolin 1 0.94
TOTAL 106

Table 7. Surgical management of SSTMSPS (Skin and soft tissue or musculoskeletal patera syndrome).

N Surgical debridement/drainage Reconstructive plastic surgery Amputation Others Location
1 Yes No No No Hand
2 Yes No No No Sacral
3 Yes No No No Leg
4 Yes No No No Hand
5 Yes Skin graft No No Hand
6 Yes Skin graft No No Foot
7 Yes Skin graft No No Ankle
8 Yes Skin graft No No Leg & Thigh
9 Yes Skin graft No No Foot
10 Yes Skin flap No No Foot
11 Yes Skin flap No No Foot
12 Yes No Trans phalangeal No Hand
13 Yes No Trans phalangeal No Hand
14 Yes No Trans phalangeal No Hand
15 Yes No Trans phalangeal No Hand
16 Yes Skin flap Trans phalangeal No Hand
17 Yes Skin flap Trans phalangeal No Hand
18 Yes Skin flap Chopart No Foot
19 Yes Skin graft Pirogoff No Foot
20 Yes No No Fasciotomy Hand
21 Yes No No Fasciotomy Foot
22 Yes No No Fasciotomy Foot
24 Yes No No Synovectomy Hand
24 Yes No No Suture for ruptured flexor tendon Hand

Discussion

Since 1997, there has been a steady increase in the number of people arriving irregularly in Spain in small boats or cayucos. In general, the Canary Islands are not their intended destination but a country of transit on their way to the rest of Europe. For this reason, the correct term for these people is migrants, as opposed to immigrants, which implies that they intend to stay in the destination country.

During the period studied, 56,224 migrants arrived by sea in the Canary Islands, of whom 193 (0.34%) required hospitalization. Although we do not have exact data on the number of patients who arrived specifically in Gran Canaria, the hospitalization rate would have been less than 0.34% (193/56,224). These figures are similar to those reported in other published studies, which indicate that the need for hospital care is generally low (2.4–2.9%) [2, 8]. It should be noted however that this figure is sometimes overestimated, as newly arrived migrants are referred without a clear reason due to the language barrier, which hinders their ability to express their symptoms [6].

Regarding age, both in our study and in the various published series [4, 68], it is more common to find young men under 25 years of age, mostly from sub-Saharan Africa. Given that they migrate in search of work and a better quality of life, the most common age group, not surprisingly, is between 18–40 years [8]. However, as our data and those of other studies show, the number of women and children has gradually increased over the years [20]. In this series, 35 women were included, 5 of whom were pregnant (2.59%), a lower figure than that reported by other authors (7.2%) [8]. On the other hand, the age of the women included in the study was significantly higher than that of the men.

The geographical origin of the patients in our series is variable, although the majority came from Mali, Morocco, and Côte d’Ivoire. These data are very different from those reported in other publications on migrants arriving by boat in the south of the Iberian Peninsula (from Algeria and Morocco) [8, 20] and in Italy (from Eritrea, Nigeria and Somalia) [7]. The migration route followed is the most likely explanation for these data (Fig 1). It should be noted that in our study practically all the women came from Côte d’Ivoire, which is explained by the violent conditions, sexual exploitation of women and genital mutilation [21].

Although all the reviewed publications indicate that the annual distribution of migrants is greater between the months of July and September [2, 6, 8], in our series, the highest number of cases occurred between the months of October and November. This may be attributed to climate change, which has shifted favorable weather conditions towards the end of the year [2]. In addition, the average water temperature in the part of the Atlantic where the Canary Islands are located is 21°C, which may favor infection with certain microorganisms, such as Shewanella algae, that are associated with coastal areas and warm temperatures [22] and contribute to the lower incidence of hypothermia (see below).

The reasons for medical care in irregular migrants vary widely between studies. For example, in some series, the most frequent cause was febrile syndrome (mainly malaria and tuberculosis) [6]; in another study, it was skin lesions (scabies or chickenpox) [7] and in other publications, skin and soft tissue lesions associated or not with dehydration [2, 8]. In our study, most of the patients were included in the previously defined syndromes: APS 36.9%, SSTMSPS 11.56% and both 51.44%. The main manifestations of acute patera syndrome were dehydration and rhabdomyolysis; the presence of hypothermia or shock were less frequently observed. The definitive diagnosis of dehydration is a complex process in clinical practice and depends on physical examination data and/or use of analytical studies (mainly plasma osmolality or natremia) [10, 11, 23]. It is not uncommon therefore for data obtained from different studies to give discrepant results. This study found that approximately one third of dehydrated patients had one of the major types: hypertonic, isotonic, or hypotonic. Factors involved in dehydration include inadequate fluid intake, ingestion of salt water or excessive fluid intake on arrival. Although studies of the effects of dehydration have primarily focused on the elderly [10, 11], it has been observed that as dehydration progresses, the body loses its ability to regulate temperature. This may contribute to hypothermia in these patients, as well as the appearance of wounds and delayed healing, contributing to the development of skin and soft tissue lesions. According to the established biochemical criteria (CK activity), approximately three-quarters of the admitted patients had rhabdomyolysis. However, it is important to note that these data may be due to ethnic factors (higher proportion of type IIa fibers and a lower proportion of type I in black individuals) not related to muscle mass or physical activity [24]. In fact, although 40% had moderate or severe rhabdomyolysis, only a minority showed elevated plasma creatinine or serum potassium. In this study, the McMahon score was calculated on admission to predict the risk of renal failure requiring renal replacement therapy (RRT) or mortality in patients with rhabdomyolysis [14]. The score was less than 6 in all patients. The incidence of hypothermia was lower than would be expected for a sea crossing in these conditions, which may be related to the warm temperature of the waters round the Canary Islands and the duration of the crossing. On the other hand, hypothermia was more frequent in cases in which APS and SSTMSPS coexisted, possibly due to the severity of the patient [12]. Skin, soft tissue or musculoskeletal injuries of varying depth and severity are very common due to the conditions of the voyage and the restraints used on boats to prevent capsizing. In contrast to the reviewed series, in which the frequency of skin and soft tissue infections was less than 10% [2, 6, 7], the data from our study were five times higher. Single anatomical site involvement was more common in the SSTMSPS and mixed groups, with no significant differences between the two. Not surprisingly, the lower extremities were the most frequently affected anatomical region, as the legs are either submerged in water contaminated with urine, feces and fuel in the cayuco or else dangling overboard during the crossing [4, 25]. However, up to a quarter of patients with SSTMSPS had upper extremity involvement, which was probably due to the arms being tethered with ropes as the vessels increase in size (from small boats to cayucos), causing injuries like those mentioned above [5]. The most frequent lesions were ulcers, followed by cellulitis. The microbiological studies that were performed showed a discrete increase in gram-negative microorganisms compared to gram-positive cocci, which differs from the general data obtained in all types of skin and soft tissue infections (SSTI) [26]. Among the gram-positive cocci, S. aureus was the most frequently isolated, which is consistent with other SSTI series, while the gram-negatives included unusual microorganisms such as Shewanella algae, Morganella morganii, Vibrio alginolyticus or Aeromonas hydrophila. This information is crucial for the choice of initial empiric treatment and the prevention of further complications.

Regarding the analytical data, it should be noted that the values considered normal for the native population are not normal for migrants, especially those of sub-Saharan origin [24]. Of note was the presence of anemia in approximately half the patients. Most was characterized as normocytic, although there was a non-negligible percentage of microcytic anemia (16.7%), related to the common hemoglobinopathies in this population [27]. Leukopenia was also very frequent, found in practically two thirds of the patients. This ethnic leukopenia is due to genetic factors, specifically to alterations in the ACKR1 gene (previously called DARC) [28], which is associated with a decrease in Plasmodium vivax infection but does not lead to a higher frequency of bacterial infections [24]. Eosinophilia was observed in only 11.6% of cases, in contrast to another series of immigrants from the same geographical region studied after their arrival in our country, which was related to the presence of helminthiasis [29]. This discrepancy has been attributed to the effect of proinflammatory cytokines on hemopoiesis [30]. Finally, it should be noted that there was no statistical association between the analytical variables and the different forms of patera foot considered.

In this group of patients, it is always important to consider other diseases present before the trip that are more common in their countries of origin or were acquired during travel. With respect to pre-travel infections, we emphasize that our data represent the expected values, based on their countries of origin, for HIV infection, previous syphilis and hepatitis B virus infection, and lower values for tuberculosis and malaria. Although it is not possible to determine the exact time of infection due to the incubation period, we found a high percentage of giardiasis, Salmonella enterica infections, but only 5 cases of scabies, which differs from another series in which scabies accounted for 58% of cases [7].

Newly arrived migrants were quarantined until the absence of SARS-CoV-2 infection could be demonstrated. SARS-CoV-2 infection was observed in one fifth of the patients. This is slightly higher than the figure published by Sisti et al [31], possibly because our study period was longer, the patients were younger and the countries of origin were different. On the other hand, the severity of SARS-CoV-2 infection was minimal, which has been explained by the so-called African paradox [32] involving genetic factors (i.e. ACE-2 gene polymorphisms), environmental factors (climate), co-infections (i.e. malaria) and average age.

A finding not reported in other patients with this syndrome but documented in 10% of patients in our series was the presence of extrapulmonary air, specifically spontaneous pneumomediastinum (20 patients) associated with subcutaneous emphysema in 8 cases. This complication usually occurs in young people [33] and males [34]. One of the main causes is frequent vomiting due to increased intrathoracic pressure (such as the Valsalva maneuver). It is well known that patients frequently ingest seawater during the crossing, which causes frequent vomiting and abdominal pain, and could explain our findings. In patients presenting with this complication, we did not observe an increase in mortality, as is usual in spontaneous pneumomediastinum. On the other hand, although the presence of extrapulmonary air has been associated with COVID-19 [35], we did not find a significant association between the presence of pneumomediastinum and concomitant SARS-CoV-2 infection in our series.

The natural evolution of skin, soft tissue and musculoskeletal lesions is poor, which is attributable to the thicker, less extensible skin and the presence of rhabdomyolysis. This causes muscle edema and decreased perfusion leading to ischemia [9, 13] and creates a compartment syndrome-like situation. Indeed, in the first description of ‘patera foot’ by our group, there were 14% of major amputations [4]. Due to better clinical management (medical and surgical), all of these patients had a good evolution and all amputations were minor [19]. Most patients were treated with amoxicillin/clavulanate, alone or in combination with other antimicrobials (mainly doxycycline). Patients with SSTMSPS were significantly more likely to be admitted to the ICU. The median length of stay was 9 days, as previously described [6], and was, as expected, significantly longer when both syndromes coexisted. In contrast to other series [6], no patient died while admitted.

This study has some limitations, the main ones being the challenges of studying this population. These include the language barrier, which prevents taking a correct anamnesis for knowledge of the underlying pathology (many of them speak only dialects of their own country, such as Wolof or Bambara), a reluctance to reveal their true origin due to the possibility of deportation because of international agreements, plus cultural or religious factors that affect the collection of samples, and transfers to other centers or places that prevent adequate follow-up [28, 20].

Conclusion

In summary, the data obtained indicate the specific characteristics of patera syndrome in newly arrived migrants so that the most effective treatment for optimal outcome can be initiated as early as possible

Acknowledgments

We thank Janet Dawson for her help in revising the English version of the manuscript. Silvia Rivero-Martel for the design of Fig 1 and Alejandro Martín-Sánchez MD, Francisco Romero-Santana MD and Raquel Martínez-Goñi MD for their contribution to the management of some patients.

Data Availability

The Repository: this has been uploaded to the stable, open repository Zenodo (DOI: 10.5281/zenodo.13807911).

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Ministerio del Interior Available online: https://www.interior.gob.es/opencms/es/prensa/balances-e-informes/ (accessed on 4 January 2024).
  • 2.Matos Castro S, Padrón Peña MP. [Urgent assistance needs for illegal immigrants recently arrived in Tenerife by cayuco boat]. Emergencias. 2008; 20: 405–10. [Google Scholar]
  • 3.Hernández Sánchez MJ, Segura Clavell J, Burillo-Putze G. [Key role of emergency services in the illegal immigration tragedy by sea]. Emergencias. 2008; 20: 377–9. [Google Scholar]
  • 4.Ternavasio-de la Vega H-G, Ángel-Moreno A, Hernández-Cabrera M, Pisos-Álamo E, Bolaños-Rivero M, Carranza-Rodriguez C, et al. Skin and soft tissue infections (patera foot) in immigrants, Spain. Emerg Infect Dis 2009; 15:598–600. doi: 10.3201/eid1504.081457 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ternavasio-de la Vega HG, Marcos-García A, Pisos-Alamo E, Bolaños-Rivero M, Hernández-Cabrera M, Pérez-Arellano JL. Compartmental syndrome of the upper limb due to Moraxella lacunata infection: a link to patera foot syndrome? Int J Infect Dis. 2010;14 Suppl 3:e302–4. [DOI] [PubMed] [Google Scholar]
  • 6.Rodríguez Del Rosario C, Núñez Díaz S, García De Carlos P, Rodríguez Palmero I, Mahtani Mahtani V, Hernández Rodríguez MA, et al. [Characteristics of the health care provided to African immigrants arriving in the Canary Islands]. Emergencias. 2008;20: 411–8. [Google Scholar]
  • 7.Di Meco E, Di Napoli A, Amato LM, Fortino A, Costanzo G, Rossi A, et al. Infectious and dermatological diseases among arriving migrants on the Italian coasts. Eur J Public Health. 2018; 28:910–916. doi: 10.1093/eurpub/cky126 [DOI] [PubMed] [Google Scholar]
  • 8.Ponce-Blandón JA, Mérida-Martín T, Jiménez-Lasserrotte MDM, Jiménez-Picón N, Macías-Seda J, Lomas-Campos MLM. Analysis of Prehospital Care of Migrants Who Arrive Intermittently at the Coasts of Southern Spain. Int J Environ Res Public Health. 2020; 17: 1964. doi: 10.3390/ijerph17061964 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Santana L, Rodríguez González F, Villanueva A, Sánchez Palacios M. [Rhabdomyolysis due to hypothermia in immigrant illegal patient who arrives in small boat]. Nefrologia. 2007;27:394. [PubMed] [Google Scholar]
  • 10.Hooper L, Bunn D, Jimoh FO, Fairweather-Tait SJ. Water-loss dehydration and aging. Mech Ageing Dev. 2014;136–137:50–8. doi: 10.1016/j.mad.2013.11.009 [DOI] [PubMed] [Google Scholar]
  • 11.Miller HJ. Dehydration in the Older Adult. J Gerontol Nurs. 2015; 41:8–13. doi: 10.3928/00989134-20150814-02 [DOI] [PubMed] [Google Scholar]
  • 12.Paal P, Pasquier M, Darocha T, Lechner R, Kosinski S, Wallner B, et al. Accidental Hypothermia: 2021 Update. Int J Environ Res Public Health. 2022; 19:501. doi: 10.3390/ijerph19010501 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Stahl K, Rastelli E, Schoser B. A systematic review on the definition of rhabdomyolysis. J Neurol. 2020; 267: 877–882. doi: 10.1007/s00415-019-09185-4 [DOI] [PubMed] [Google Scholar]
  • 14.Cabral BMI, Edding SN, Portocarrero JP, Lerma EV. Rhabdomyolysis. Dis Mon. 2020; 66: 101015. doi: 10.1016/j.disamonth.2020.101015 [DOI] [PubMed] [Google Scholar]
  • 15.Farkas, J. Rhabdomyolysis. Available online: https://emcrit.org/ibcc/rhabdo/ (accessed on 4 January 2024).
  • 16.Baeza-Trinidad R. Rhabdomyolysis: A syndrome to be considered. Med Clin (Barc). 2022; 158: 277–283. [DOI] [PubMed] [Google Scholar]
  • 17.McMahon GM, Zeng X, Waikar SS. A Risk Prediction Score for Kidney Failure or Mortality in Rhabdomyolysis. JAMA Intern Med. 2013; 173:1821–1828. doi: 10.1001/jamainternmed.2013.9774 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Zhou M, Zhang X, Qu J. Coronavirus Disease 2019 (COVID-19): A Clinical Update. Front. Med. 2020, 14, 126–135. doi: 10.1007/s11684-020-0767-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ratliff HT, Shibuya N, Jupiter DC. Minor vs. major leg amputation in adults with diabetes: Six-month readmissions, reamputations, and complications. J Diabetes Complications. 2021; 107886. [DOI] [PubMed] [Google Scholar]
  • 20.Jiménez-Lasserrotte MDM, Artés-Navarro R, Granero-Molina J, Fernández Medina IM, Ruiz-Fernández MD, Ventura-Miranda MI. Experiences of Healthcare Providers Who Provide Emergency Care to Migrant Children Who Arriving in Spain by Small Boats (Patera): A Qualitative Study. Children (Basel) 2023; 10: 1079. doi: 10.3390/children10061079 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.García D. [Côte d’Ivoire: Status of women]. Available online: https://www.cear.es/wp-content/uploads/2020/01/Costa de Marfil (accessed on 22 March 2024). [Google Scholar]
  • 22.Martín-Rodríguez AJ, Martín-Pujol O, Artiles-Campelo F, Bolaños-Rivero M, Römling U. Shewanella spp. Infections in Gran Canaria, Spain: retrospective analysis of 31 cases and a literature review. JMM Case Reports 2017;4: e005131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Armstrong LE. Assessing hydration status: the elusive gold standard. J Am Coll Nutr. 2007; 26(5 Suppl):575S–584S. doi: 10.1080/07315724.2007.10719661 [DOI] [PubMed] [Google Scholar]
  • 24.Sanz-Peláez O, Ángel-Moreno A, Tapia-Martín M, Conde-Martel A, Carranza-Rodríguez C, Carballo-Rastrilla S et al. [Reference values in the usual laboratory data for sub-Saharan immigrants. Importance in the management of infectious diseases]. Rev Clin Esp 2008;208:386–92. [DOI] [PubMed] [Google Scholar]
  • 25.Laynez-Roldán P, Gómez Álvarez MP, Pérez Hernández O, García Martínez de Artola D, Almuedo-Riera A, Rodríguez-Valero N. Necrotizing soft tissue infection by Vibrio furnissii after a migratory journey by sea to the Canary Islands (Spain). Travel Med Infect Dis 2023; 57:102678. [DOI] [PubMed] [Google Scholar]
  • 26.Stevens DL, Bisno AL, Chambers AF, Patchen Dellinger E, Goldstein EJC, Gorbach SL et al. Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America. CID 2014; 59: e10–52 [DOI] [PubMed] [Google Scholar]
  • 27.De-la-Iglesia-Íñigo S, Carranza-Rodríguez C, Ropero-Gradilla C, González-Fernández FA, Molero-Labarta T, Hemmersbach-Miller M et al. Red blood cell disorders in recently arrived African immigrants to Gran Canaria, Spain. Trans R Soc Trop Med Hyg 2013;107: 91–7. doi: 10.1093/trstmh/trs017 [DOI] [PubMed] [Google Scholar]
  • 28.Rappoport N, Simon AJ, Amariglio N, Rechavi G. The Duffy antigen receptor for chemokines, ACKR1,- ’Jeanne DARC’ of benign neutropenia. Br J Haematol. 2019; 184:497–507. doi: 10.1111/bjh.15730 [DOI] [PubMed] [Google Scholar]
  • 29.Pardo J, Carranza C, Muro A, Ángel-Moreno A, Martín AM, Martín T et al. Helminth-related Eosinophilia in African Immigrants, Gran Canaria. Emerging Infectious Diseases 2006;12: 1587–9. doi: 10.3201/eid1210.060102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Pérez Arellano JL, Pardo J, Hernández Cabrera M, Carranza C, Angel Moreno A, Muro A. [Eoshinophilia: a practical approach]. An Med Interna. 2004. May;21(5):244–52 [DOI] [PubMed] [Google Scholar]
  • 31.Sisti LG, Di Napoli A, Petrelli A, Diodati A, Cavani A, Mirisola C et al. Newly arrived migrants did not represent an additional COVID-19 burden for Italy: data from the Italian information flow. Global Health. 2023; 19:32 doi: 10.1186/s12992-023-00926-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Ghosh D, Bernstein JA, Mersha TB. COVID-19 pandemic: The African paradox. J Glob Health. 2020; 10: 020348. doi: 10.7189/jogh.10.020348 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Caceres M, Ali SZ, Braud R, Weiman D, Garrett HE Jr. Spontaneous pneumomediastinum: a comparative study and review of the literature. Ann Thorac Surg. 2008; 86:962–6. doi: 10.1016/j.athoracsur.2008.04.067 [DOI] [PubMed] [Google Scholar]
  • 34.Macia I, Moya J, Ramos R, Morera R, Escobar I, Saumench J, et al. Spontaneous pneumomediastinum: 41 cases. Eur J Cardiothorac Surg. 2007; 31: 1110–4. doi: 10.1016/j.ejcts.2007.03.008 [DOI] [PubMed] [Google Scholar]
  • 35.Diaz A, Patel D, Sayedy N, Anjum F. COVID-19 and Spontaneous pneumo-mediastinum: A case series. Heart Lung. 2021; 50:202–205. doi: 10.1016/j.hrtlng.2020.12.002 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Felix Bongomin

Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

9 Sep 2024

PONE-D-24-30053‘Patera syndrome’ during the COVID-19 pandemic in the Canary Islands (Spain)PLOS ONE

Dear Dr. Carranza-Rodriguez,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Oct 24 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Felix Bongomin, MB ChB, MSc, MMed, FECMM

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Thank you for uploading your study's underlying data set. Unfortunately, the repository you have noted in your Data Availability statement does not qualify as an acceptable data repository according to PLOS's standards. At this time, please upload the minimal data set necessary to replicate your study's findings to a stable, public repository (such as figshare or Dryad) and provide us with the relevant URLs, DOIs, or accession numbers that may be used to access these data.  For a list of recommended repositories and additional information on PLOS standards for data deposition, please see https://journals.plos.org/plosone/s/recommended-repositories. 3. In the online submission form, you indicated that your data will be submitted to a repository upon acceptance.  We strongly recommend all authors deposit their data before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire minimal  dataset will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. 4. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 5. We note that Figure 1 in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright. We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission: 1. You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license.   We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.” Please upload the completed Content Permission Form or other proof of granted permissions as an ""Other"" file with your submission. In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].” 2. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.The following resources for replacing copyrighted map figures may be helpful: USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.htmlNASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/Landsat: http://landsat.visibleearth.nasa.gov/USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#Natural Earth (public domain): http://www.naturalearthdata.com/

7. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: N/A

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The paper describes the called “Patera syndrome” during the COVID-19 pandemic in the Canary Islands (Spain). First, I am agreeing with the title, especially with the “patera patients and syndrome” terms. It is very illustrative and true. The bibliography is actual and appropriate.

It is generally well written and not too long (However, the data should be provided as supplementary material, especially those used for the data analysis). The purpose of the study is well explained in the introduction and appears to be adequately referenced. The conclusions are brief but summarize the obtained results well.

However, the statistical analysis is poor or incomplete. The authors provided a section called “statistical analysis” (see line 198), where the different statistic tests are described and its application. However, the obtained results from the different contrast or situations were not provided or simply commented and discussed in the paper. For instance, in the Table 2 and Table 5, the authors used different test but any information about the results was provided. In the Table 2, only the criteria for APS was significative (p<0.05), whereas it was not significance for the rest of contrast. A similar situation was observed for the Table 5 results. This needs an explanation.

In the Discussion section (see lines 434-448) the authors speak on the analytical data but any information was provided. In this context, the authors comments data in terms of percentages on different clinical situations but no statistical analysis data.

In addition, there is a section called “Analytical data” (see lines 280-285). The authors says “However, there was no significant correlation between determinations obtained at the two time points”. What does this sentence mean? It is very confused. Does this apply only to laboratory data or to all variables used to define PSA? This needs some explanation.

In opinion of this reviewer, the manuscript is suitable for publication in the PLOS ONE Journal after minor revision.

Reviewer #2: This work is a retrospective study of patients who are admitted to a University Hospital after a crossing in patera, arriving to the island of Gran Canaria. The work is well developed and presented, and provides relevant information on this type of patients. We set out below some issues that in our opinion should be clarified.

Major issues:

1- The title should be improved, as it does not only relate to Patera Syndrome, but also to Skin and soft tissue or musculoskeletal patera syndrome (SSTMSPS). Perhaps including “COVID-19” in the title is misleading in terms of the objective of the article, since the data on this disease are very few and of a marginal nature with respect to other pathologies detected.

2- The bibliographic reference of the definition of APS and SSTMSPS is not clear. Is it being defined by the authors for the first time? If so, other conditions should in our opinion be included in APS, such as cardiorespiratory arrest (even if they had no cases in their series). The division of SSTMSPS, from the APS, of which we believe it is a part, should also be justified.

3- Given that probably not all patients who come to the hospital emergency department are admitted, the admission criteria should be included. Is it understood that all patients with PHC criteria were admitted to the ward or did some remain in the Emergency Department and were later discharged?

4- As these were severe cases, was there any out-of-hospital treatment on arrival and prior to admission to the Hospital (serum therapy, etc)?

Minor questions:

1- Line 90. Indicate how many of the migrants from the province of Las Palmas correspond to the island of Gran Canaria, where the study was carried out (therefore not including the islands of Lanzarote and Fuerteventura).

2- Line 134. Is this hospital the reference center for all the migrants on patera or is there another university hospital on the island that could attend them?

3- M&M: did all the patients come to the Hospital directly from the port or did some of them come later, from the interbording center?

4- Discussion:

- Line 344. I think there is an error, as the series only includes data from one of the hospitals in the Canary Islands. If the 56,000 are only from the island of Gran Canaria, this should be made clear in the text. This is important when calculating the % requiring hospitalization, which in any case would be very low.

-Should pneumomedicine be included as a criterion for PHC?

- Did they receive admissions from other islands (Lanzarote and Fuerteventura)?

- It should be noted that, after the study, the pressure of arrivals has moved to the island of El Hierro, where there have been some deaths in hospital care and transfers in critical condition to the referral hospital. (Mora Peces I, Galvez Rodríguez M. Seven nights, Sept nuits. Emergencias. 2024;36:148-148. Mora Peces I, Gálvez Rodríguez M. Health response of El Hierro to maritime migration in 2023. Rev Esp Urg Emerg. 2024;3:1-2)

5- Limitations:

-Possible attendances in other centers on the island of Gran Canaria?

-Missed cases of final diagnosis (line 245), should be included in the limitations and indicate possible reasons for these losses.

6- Tables and figures:

- Figure 3: Distribution of arrivals by month. Does this refer to arrivals on the island of Gran Canaria, the province or the entire Canary archipelago?

- Figure 5. The pneumomediastinum images do not seem to provide new information. We suggest deleting it.

Reviewer #3: The ‘patera syndrome’ during the COVID-19 pandemic in the Canary Islands (Spain)’ is a well-written review of patients treated for “patera syndrome” in a specific significant setting.

Concept, data and presentation of the work will be interesting for the future management of this type of patients.

Minor comments

- If possible, it would be very interesting to complete the text with data on antibiotic treatment, especially initial empirical treatment. A new table in “RESULTS” and a clear conclusion in the last part of the DISCUSSION are recommended.

- The reviewer assumes that there are few specimens for pathological review. But still, if possible, consider adding histological data from the amputation specimens: inflammation only? vasculitic findings?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Oct 24;19(10):e0312355. doi: 10.1371/journal.pone.0312355.r002

Author response to Decision Letter 0


27 Sep 2024

Dear Mr. Bongomin:

Thank you very much for your comments, as well as those of the three reviewers. A detailed response is attached. Please let us know if we can be of any further assistance.

Academic editor:

1. With respect to the style requirements, we have adapted the previous manuscript in accordance with the PLOS ONE style templates , both in the “Revised Manuscript with Track Changes” file and in the “Manuscript” file.

2. The 5 figures have been converted to tif format using the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool.

3. Figure 1 was created by Silvia Rivero-Martel (see Acknowledgements), by adding the migration routes to the map accessible through the web (https://d-maps.com/index.php?lang=es), more specifically https://d-maps.com/carte.php?num_car=3138&lang=es.

This application is freely available and the conditions of use are attached:

However, both figure and the references in the text may be deleted if it is deemed necessary.

4. We have reviewed the reference list and confirm that it is complete and correct.

5. The Ethics statement has been unified and can be found in the Patients and Methods section.

6. The Repository: this has been uploaded to the stable, open repository Zenodo (DOI: 10.5281/zenodo.13807911).

Reviewers’ Comments to the Author:

Reviewer #1:

The paper describes the called “Patera syndrome” during the COVID-19 pandemic in the Canary Islands (Spain). First, I am agreeing with the title, especially with the “patera patients and syndrome” terms. It is very illustrative and true. The bibliography is actual and appropriate. It is generally well written and not too long (However, the data should be provided as supplementary material, especially those used for the data analysis). The purpose of the study is well explained in the introduction and appears to be adequately referenced. The conclusions are brief but summarize the obtained results well. Thank you for your comments.

However, the statistical analysis is poor or incomplete. The authors provided a section called “statistical analysis” (see line 198), where the different statistic tests are described and its application. However, the obtained results from the different contrast or situations were not provided or simply commented and discussed in the paper. For instance, in the Table 2 and Table 5, the authors used different test but any information about the results was provided. In the Table 2, only the criteria for APS was significative (p<0.05), whereas it was not significance for the rest of contrast. A similar situation was observed for the Table 5 results. This needs an explanation. In the Discussion section (see lines 434-448) the authors speak on the analytical data but any information was provided. In this context, the authors comments data in terms of percentages on different clinical situations but no statistical analysis data.

With all due respect, we do not really understand these observations. Both Table 2 and Table 5 give the descriptive results, the statistical tests used and statistical significance. In the Discussion section we have added brief information about the lack of differences between APS and SSTMPS. At the same time, much of the analytical data (i.e. serum ions, osmolality, CK activity, plasma creatinine) are included in the previous section on APS criteria.

In addition, there is a section called “Analytical data” (see lines 280-285). The authors says “However, there was no significant correlation between determinations obtained at the two time points”. What does this sentence mean? It is very confused. Does this apply only to laboratory data or to all variables used to define PSA? This needs some explanation.

We fully agree with the reviewer that the text is confusing and has been modified to make it clearer. What we wanted to say was that the hematimetric and biochemical data in particular show notable differences between the initial samples obtained and those taken at 72h (see Repository). Therefore, we used the initial analytical data to define APS, but then compared the data later when the situation was more stable (72h).

In opinion of this reviewer, the manuscript is suitable for publication in the PLOS ONE Journal after minor revision. Thank you once again for your comments .

Reviewer #2:

This work is a retrospective study of patients who are admitted to a University Hospital after a crossing in patera, arriving to the island of Gran Canaria. The work is well developed and presented, and provides relevant information on this type of patients. Thank you for your comments.

We set out below some issues that in our opinion should be clarified.

Major issues:

1- The title should be improved, as it does not only relate to Patera Syndrome, but also to Skin and soft tissue or musculoskeletal patera syndrome (SSTMSPS).

We agree with reviewers 1 and 3 that “Patera syndrome” is appropriate since it serves as an umbrella term for both Acute Patera Syndrome and SSTMSPS

Perhaps including “COVID-19” in the title is misleading in terms of the objective of the article, since the data on this disease are very few and of a marginal nature with respect to other pathologies detected.

We think that the reference to the COVID-19 pandemic is relevant for at least two reasons: a) it was one of the factors that triggered the sharp increase in irregular migration from Africa to the Canary Islands, and b) hospitals in the Canary Islands, and specifically in Gran Canaria, were overwhelmed by the number of patients.

2- The bibliographic reference of the definition of APS and SSTMSPS is not clear. Is it being defined by the authors for the first time?

Yes, the definitions of Patera syndrome, APS and SSTMPS are the authors’ own.

If so, other conditions should in our opinion be included in APS, such as cardiorespiratory arrest (even if they had no cases in their series).

Previous cardiorespiratory arrest would already be included in the defined criteria .

The division of SSTMSPS, from the APS, of which we believe it is a part, should also be justified.

The two syndromes are not mutually exclusive; in fact, this is specifically noted in the text.

3- Given that probably not all patients who come to the hospital emergency department are admitted, the admission criteria should be included.

As this was a retrospective study, the criteria for admission and referral were the usual emergency department criteria..

4- As these were severe cases, was there any out-of-hospital treatment on arrival and prior to admission to the Hospital (serum therapy, etc)?

Obviously, on arrival, the patients were treated with the conventional measures for control of dehydration, hypothermia, shock and wound care, among other things, and then referred to hospital if more serious data were observed.

Minor questions:

1- Line 90. Indicate how many of the migrants from the province of Las Palmas correspond to the island of Gran Canaria, where the study was carried out (therefore not including the islands of Lanzarote and Fuerteventura).

It is difficult to determine exactly how irregular migrants arriving in the Canary Islands by sea were distributed by island /province, On the one hand, there are no accessible official data (such as those from the Ministry of the Interior) and on the other, those that are available vary according to source and time period. Thus, according to the Red Cross, in the year 2020 (January 1 to December 31) (https://www2.cruzroja.es/web/ahora/inmigracion-canarias#), the places with the highest number of migrants were Gran Canaria, Tenerife and Fuerteventura, receiving 16,463, 3,669, and 1,394 persons respectively. However newspaper data from 2023 indicate that 7,800 migrants arrived on the island of Gran Canaria and 3,250 on Lanzarote

(https://www.elindependiente.com/espana/2024/01/03/ and https://www.lancelotdigital.com/lanzarote/). Finally, as you point out in the reference (Mora Peces I, Gálvez Rodríguez M. Health response of El Hierro to maritime migration in 2023. Rev Esp Urg Emerg. 2024;3:1-2), the pressure of arrivals has shifted to the island of El Hierro, where there have been some deaths in hospital care and transfers in critical condition to the referral hospital (in this case on the island of Tenerife).

2- Line 134. Is this hospital the reference center for all the migrants on patera or is there another university hospital on the island that could attend them.

El Complejo Hospitalarario Universitario Insular Materno Infantil is the reference center on the island for obvious reasons, including the fact that it covers the south of Gran Canaria. However, during the study period, when the hospital was saturated with patients with Covid-related needs, some patients were transferred to the other University Hospital on the island (Dr. Negrín).

3- M&M: did all the patients come to the Hospital directly from the port or did some of them come later, from the interbording center?

Already answered previously.

4- Discussion:

-Line 344. I think there is an error, as the series only includes data from one of the hospitals in the Canary Islands. If the 56,000 are only from the island of Gran Canaria, this should be made clear in the text. This is important when calculating the % requiring hospitalization, which in any case would be very low.

Indeed, this was due to the difficulty in obtaining data, and we have now clarified this in the new version.

-Should pneumomedicine be included as a criterion for PHC?

We think not, because although they are relatively common, they are neither sensitive nor specific.

- Did they receive admissions from other islands (Lanzarote and Fuerte-ventura)?

None of the admissions included patients from the other islands (Lanzarote and Fuerteventura) in the province of Las Palmas.

5- Limitations:

-Possible attendances in other centers on the island of Gran Canaria

Already answered.

-Missed cases of final diagnosis (line 245), should be included in the limitations and indicate possible reasons for these losses.

In 9 patients, a definitive diagnosis could not be made despite the tests carried out. This information is included in the limitations of the study. Any interpretation of this data is speculative.

.

6- Tables and figures:

- Figure 3: Distribution of arrivals by month. Does this refer to arrivals on the island of Gran Canaria, the province or the entire Canary archipelago?

The results are for the Canary Islands archipelago; specific data were not available, as previously stated.

- Figure 5. The pneumomediastinum images do not seem to provide new information. We suggest deleting it.

None of the images of extrapulmonary air actually provide new radiological information; we thought it was interesting to attach them in the context of this syndrome. Nevertheless, if you consider it appropriate, this figure can be deleted.

Reviewer #3:

The ‘patera syndrome’ during the COVID-19 pandemic in the Canary Islands (Spain)’ is a well-written review of patients treated for “patera syndrome” in a specific significant setting. Concept, data and presentation of the work will be interesting for the future management of this type of patients.

Minor comments

- If possible, it would be very interesting to complete the text with data on antibiotic treatment, especially initial empirical treatment. A new table in “RESULTS” and a clear conclusion in the last part of the DISCUSSION are recommended.

Empirical antimicrobial treatment varied a good deal depending, among other things, on the extent and depth of the lesions and the prescribing physician. We have added a new table (6) and a mention of this in the discussion.

- The reviewer assumes that there are few specimens for pathological review. But still, if possible, consider adding histological data from the amputation specimens: inflammation only? vasculitic findings?

Unfortunately, we do not have histopathologic data on the amputation specimens.

Attachment

Submitted filename: Response to Reviewers.docx

pone.0312355.s001.docx (204.4KB, docx)

Decision Letter 1

Felix Bongomin

7 Oct 2024

‘Patera syndrome’ during the COVID-19 pandemic in the Canary Islands (Spain)

PONE-D-24-30053R1

Dear Dr. Carranza-Rodriguez,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Felix Bongomin, MB ChB, MSc, MMed, FECMM

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Felix Bongomin

13 Oct 2024

PONE-D-24-30053R1

PLOS ONE

Dear Dr. Carranza-Rodriguez,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Felix Bongomin

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0312355.s001.docx (204.4KB, docx)

    Data Availability Statement

    The Repository: this has been uploaded to the stable, open repository Zenodo (DOI: 10.5281/zenodo.13807911).


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES